Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells

Chemico-Biological Interactions

Volumn 186, Issue 3, 2010, Pages 280-286

  Dupuy, Jacques ^a   Alvinerie, Michel ^a   Ménez, Cecile ^a   Lespine, Anne ^a  

^a CEMAGREF   (France)

Author keywords

Anthelmintics; Cytotoxicity; P glycoprotein; Rhodamine 123

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; CLORSULON; CLOSANTEL; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; MULTIDRUG RESISTANCE PROTEIN 1; NITROXINIL; OXFENDAZOLE; PRAZIQUANTEL; RAFOXANIDE; RHODAMINE 123; TIABENDAZOLE; TRICLABENDAZOLE; TRICLABENDAZOLE SULFONE; TRICLABENDAZOLE SULFOXIDE; UNCLASSIFIED DRUG; VALSPODAR;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG TRANSPORT; IN VITRO STUDY; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTHELMINTICS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; LLC-PK1 CELLS; P-GLYCOPROTEIN; RHODAMINE 123; SWINE; UP-REGULATION;

EID: 77954427586     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.05.013     Document Type: Article

References (45)

1. Waller P.J. Global perspectives on nematode parasite control in ruminant livestock: the need to adopt alternatives to chemotherapy, with emphasis on biological control. Anim. Health Res. Rev. 2003, 4(1):35-43.
2. Martin R.J Modes of action of anthelmintic drugs. Vet. J. 1997, 154(1):11-34.
3. Wolstenholme A.J., Fairweather I., Prichard R., von Samson-Himmelstjerna G., Sangster N.C. Drug resistance in veterinary helminths. Trends Parasitol. 2004, 20(10):469-476.
4. Kaplan R.M. Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. 2004, 20(10):477-481.
5. Fairweather I., Boray J.C. Fasciolicides: efficacy, actions, resistance and its management. Vet. J. 1999, 158(2):81-112.
6. Mejia M.E, Fernandez Igartua B.M., Schmidt E.E., Cabaret J. Multispecies and multiple anthelmintic resistance on cattle nematodes in a farm in Argentina: the beginning of high resistance?. Vet. Res. 2003, 34(4):461-467.
7. Sager H., Hosking B., Bapst B., Stein P., Vanhoff K., Kaminsky R. Efficacy of the amino-acetonitrile derivative, monepantel, against experimental and natural adult stage gastro-intestinal nematode infections in sheep. Vet. Parasitol. 2009, 159(1):49-54.
8. Brayden D.J, Griffin J. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers. Vet. Res. Commun. 2008, 32(1):93-106.
9. Lespine A., Dupuy J., Orlowski S., Nagy T., Glavinas H., Krajcsi P., Alvinerie M. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem. Biol. Interact. 2006, 159(3):169-179.
10. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 2007, 30(1):84-94.
11. Merino G., Jonker J.W., Wagenaar E., Pulido M.M., Molina A.J., Alvarez A.I., Schinkel A.H. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab. Dispos. 2005, 33(5):614-618.
12. Perez M., Blazquez A.G., Real R., Mendoza G., Prieto J.G., Merino G., Alvarez A.I. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2. Chem. Biol. Interact. 2009, 180(1):106-112.
13. Kiki-Mvouaka S., Menez C., Borin C., Lyazrhi F., Foucaud-Vignault M., Dupuy J., Collet X., Alvinerie M., Lespine A. Role of P-glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin, and moxidectin in mice. Drug Metab. Dispos. 2010, 38(4):573-580.
14. Alvinerie M., Dupuy J., Eeckhoutte C., Sutra J.F. Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil. Parasitol. Res. 1999, 85(11):920-922.
15. Dupuy J., Larrieu G., Sutra J.F., Lespine A., Alvinerie M. Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet. Parasitol. 2003, 112(4):337-347.
16. James C.E., Hudson A.L., Davey M.W. Drug resistance mechanisms in helminths: is it survival of the fittest?. Trends Parasitol. 2009, 25(7):328-335.
17. Sangster N.C., Bannan S.C., Weiss A.S., Nulf S.C., Klein R.D., Geary T.G. Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins. Exp. Parasitol. 1999, 91(3):250-257.
18. Xu M., Molento M., Blackhall W., Ribeiro P., Beech R., Prichard R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. 1998, 91:327-335.
19. Kumkate S., Chunchob S., Janvilisri T. Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics. Mol. Cell. Biochem. 2008, 317(1-2):77-84.
20. James C.E., Davey M.W. Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. Int. J. Parasitol. 2009, 39(2):213-220.
21. Prichard R.K., Roulet A. ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development. Parasitology 2007, 134(Pt. 8):1123-1132.
22. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150(1):76-85.
23. Goh L.B., Spears K.J., Yao D.G., Ayrton A., Morgan P., Wolf C.R., Friedberg T. Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Biochem. Pharmacol. 2002, 64(11):1569-1578.
24. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 1995, 96(4):1698-1705.
25. Henessy D., Alvinerie M. Pharmacokinetics of the macrocycle lactones: conventional wisdom and new paradigms. Macrocyclic Lactones in Antiparasitic Therapy 2002, 97-123. Cabi Publishing, Wallingford. J. Vercruysse, R.S. Rew (Eds.).
26. Garrigues A., Loiseau N., Delaforge M., Ferte J., Garrigos M., Andre F., Orlowski S. Characterization of two pharmacophores on the multidrug transporter P-glycoprotein. Mol. Pharmacol. 2002, 62(6):1288-1298.
27. Merino G., Alvarez A.I., Prieto J.G., Kim R.B. The anthelmintic agent albendazole does not interact with p-glycoprotein. Drug Metab. Dispos. 2002, 30(4):365-369.
28. Pulido M.M., Molina A.J., Merino G., Mendoza G., Prieto J.G., Alvarez A.I. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. J. Vet. Pharmacol. Ther. 2006, 29(4):279-287.
29. Lifschitz A., Virkel G., Ballent M., Sallovitz J., Lanusse C. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction. Vet. J. 2008.
30. Suzuki H., Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 2000, 12(1):3-12.
31. Merino G., Molina A.J., Garcia J.L., Pulido M.M., Prieto J.G., Alvarez A.I. Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors. Int. J. Pharm. 2003, 263(1-2):123-132.
32. Cromie L., Ferry M., Couper A., Fields C., Taylor S.M. Pharmacokinetics of a novel closantel/ivermectin injection in cattle. J. Vet. Pharmacol. Ther. 2006, 29(3):205-211.
33. El-Banna H.A., Goudah A., El-Zorba H., Abd-El-Rahman S. Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep. Parasitol. Res. 2008, 102(6):1337-1342.
34. Borgsteede F.H., Taylor S.M., Gaasenbeek C.P., Couper A., Cromie L. The efficacy of an ivermectin/closantel injection against experimentally induced infections and field infections with gastrointestinal nematodes and liver fluke in cattle. Vet. Parasitol. 2008, 155(3-4):235-241.
35. Stevenson C.R., Mahoney R.H., Fisara P., Strehlau G., Reichel M.P. The efficacy of formulations of triclabendazole and ivermectin in combination against liver fluke (Fasciola hepatica) and gastro-intestinal nematodes in cattle and sheep and sucking lice species in cattle. Aust. Vet. J. 2002, 80(11):698-701.
36. Dupuy J., Lespine A., Sutra J.F., Alvinerie M. The interaction between moxidectin and MDR transporters in primary cultures of rat hepatocytes. J. Vet. Pharmacol. Ther. 2006, 29(2):107-111.
37. Alvinerie M., Dupuy J., Kiki-Mvouaka S., Sutra J.F., Lespine A. Ketoconazole increases the plasma levels of ivermectin in sheep. Vet. Parasitol. 2008.
38. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Lanusse C. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition. J. Vet. Pharmacol. Ther. 2007, 30(3):242-248.
39. Lifschitz A., Virkel G., Sallovitz J., Imperiale F., Pis A., Lanusse C. Loperamide-induced enhancement of moxidectin availability in cattle. J. Vet. Pharmacol. Ther. 2002, 25(2):111-120.
40. Mohammed K.A., Haji H.J., Gabrielli A.F., Mubila L., Biswas G., Chitsulo L., Bradley M.H., Engels D., Savioli L., Molyneux D.H. Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. PLoS Negl. Trop. Dis. 2008, 2(1):e171.
41. Olsen A Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 2007, 101(8):747-758.
42. Guzzo C.A., Furtek C.I., Porras A.G., Chen C., Tipping R., Clineschmidt C.M., Sciberras D.G., Hsieh J.Y., Lasseter K.C. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J. Clin. Pharmacol. 2002, 42(10):1122-1133.
43. El-Tantawy W, Salem H., Mohammed Safwat N. Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects. Pharm. World Sci. 2007, 29(3):190-198.
44. Pouliot J.F., L'Heureux F., Liu Z., Prichard R.K., Georges E. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. 1997, 53:17-25.
45. Roulet A., Puel O., Gesta S., Lepage J.F., Drag M., Soll M., Alvinerie M., Pineau T. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. Eur. J. Pharmacol. 2003, 460(2-3):85-91.